Skip to main content
VOR
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai•Reviewed by Editorial Team
Sentiment info
Neutral
Importance info
4
Price
$14.18
Mkt Cap
$689.727M
52W Low
$2.622
52W High
$65.8
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, VOR was trading at $14.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $689.7M. The 52-week trading range was $2.62 to $65.80. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed VOR - Latest Insights

VOR
Apr 27, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Shareholders to Vote on Equity Plan Expanding Dilution Base; Executive Options Repriced Amidst Financial Challenges
Sentiment: Negative
View Wiseek Article
VOR
Apr 21, 2026, 7:04 PM EDT
Filing Type: 4
Importance Score:
7
RA Capital Continues Significant Share Sales, Disposing of Another $10.17M in Vor Biopharma Stock
Sentiment: Negative
View Wiseek Article
VOR
Apr 15, 2026, 5:31 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
RA Capital reports additional $11.88M sale of Vor Biopharma shares, reducing stake
Sentiment: Negative
View Wiseek Article
VOR
Apr 15, 2026, 5:29 PM EDT
Filing Type: 4
Importance Score:
8
Major Investor RA Capital Continues Significant Share Sales in Vor Biopharma
Sentiment: Negative
View Wiseek Article
VOR
Apr 10, 2026, 6:25 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
RA Capital Reduces Vor Biopharma Stake by $10.2M, Now Owns 19.9%
Sentiment: Negative
View Wiseek Article
VOR
Apr 10, 2026, 6:23 PM EDT
Filing Type: 4
Importance Score:
8
RA Capital Healthcare Fund LP Sells Over $10 Million in Vor Biopharma Shares
Sentiment: Negative
View Wiseek Article
VOR
Apr 06, 2026, 6:51 PM EDT
Filing Type: 4
Importance Score:
7
RA Capital Sells $14.5M in Vor Biopharma Shares Following Recent Financial Disclosures
Sentiment: Negative
View Wiseek Article
VOR
Mar 30, 2026, 8:05 AM EDT
Source: Wiseek News
Importance Score:
8
Vor Biopharma's 10-K Reveals $696M Net Loss, Cash Runway Secured Into Early 2029
Sentiment: Neutral
View Wiseek Article
VOR
Mar 30, 2026, 8:03 AM EDT
Filing Type: 10-K
Importance Score:
8
Vor Biopharma Reports $696M Net Loss, Negative Equity, but Secures $75M Private Placement to Extend Runway into Early 2029
Sentiment: Negative
View Wiseek Article
VOR
Mar 27, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Vor Biopharma Secures $75M Private Placement to Fund Clinical Pipeline
Sentiment: Positive
View Wiseek Article